Trump enacts new drug price deals
President Donald Trump announced the signing of new agreements with nine pharmaceutical companies to voluntarily reduce drug prices, aligning them with international prices and offering discounts on medications for chronic and rare diseases within government healthcare programs. These agreements include companies such as "Alcon," "Astellas Pharma," and "San Farma," bringing the total number of participating companies to 26, representing 90% of the U.S. pharmaceutical market. This initiative comes amid efforts to lower costs and implement a "Most Favored Nation" policy ahead of the midterm elections.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)